Individual isoforms of a protein may be differentially expressed in different cancer types or individual cancer cells [39], which may provide adaptive resistance to targeted therapy [40], and we and others have shown the subtleties of differential functional effects of SphK1 isoform expression in cell studies in vitro [33, 35, 36]. This evidence concerns the gene SPHK1 and cancer.